Organ Transplant Eligibility: What Transplant Centers Evaluate Before Accepting a Patient

One of the first questions many patients and families ask is:

“Am I eligible for an organ transplant?”

There is no single universal answer.

Transplant eligibility depends on the type of organ needed, the patient's medical condition, the expected benefits and risks of transplantation, the policies of the transplant center and, in some cases, national regulations or donor-related requirements.

A patient who is accepted by one transplant program may not necessarily meet the criteria of another. Likewise, a patient who is initially considered unsuitable may sometimes become eligible after additional treatment, stabilization or further evaluation.

For international patients, eligibility can involve another layer of assessment because transplant centers may have specific rules for non-resident patients.

This guide explains what transplant centers commonly evaluate and why formal transplant eligibility can only be determined by the transplant program itself.

What does transplant eligibility mean?

Transplant eligibility means that a transplant center has assessed whether transplantation is medically appropriate and whether the patient can safely proceed through the transplant process under that program's criteria.

Eligibility is not based on one laboratory test or one diagnosis.

• A transplant team may evaluate:
• the severity of organ failure
• the likelihood that transplantation will improve survival or quality of life
• other medical conditions
• surgical risk
• infection risk
• cancer history
• cardiovascular health
• ability to tolerate immunosuppressive treatment
• psychosocial factors
• adherence to medical care

and the availability of an appropriate donor or allocation pathway.

The exact criteria vary by transplant type and center.

Who decides whether a patient is eligible?

The transplant center does.

A referring physician, international patient office or navigation platform may help determine whether a case is appropriate to submit for review, but they cannot independently declare a patient eligible for transplantation.

This distinction is important.

A responsible pathway looks like this:

Not:

MedTransplant provides international transplant navigation and referral support, but final eligibility decisions remain entirely with the licensed transplant program.

Does diagnosis alone determine eligibility?

For example, two people with advanced kidney disease may differ in:

cardiovascular health;

infection status;

• cancer history
• age and functional condition
• previous surgeries
• vascular anatomy
• dialysis complications
• other chronic illnesses.
• Similarly, two patients with advanced liver disease may have different levels of disease severity, complications, cancer status and operative risk.

For this reason, transplant centers usually perform a comprehensive evaluation rather than relying solely on the organ diagnosis.

What medical conditions may affect transplant eligibility?

Different transplant programs use different criteria, but several areas are commonly considered.

Cardiovascular health

Major transplant surgery places significant stress on the heart and circulation.

Patients may need cardiac testing to determine whether surgery can be performed safely.

Depending on age, symptoms and medical history, evaluation may involve electrocardiography, echocardiography, stress testing or additional cardiology assessment.

Cardiovascular disease does not automatically exclude every patient, but severe uncontrolled disease may affect eligibility.

Active infection

Transplant recipients generally require immunosuppressive medications that reduce immune-system activity.

An uncontrolled infection can therefore become significantly more dangerous after transplantation.

A transplant team may delay transplantation while an infection is investigated or treated.

This is an example of why being “not eligible today” does not necessarily mean a patient will never become eligible.

Cancer history

Active malignancy can affect transplant eligibility because immunosuppression may increase the risk of cancer progression or recurrence.

The transplant team may review:

cancer type;

stage;

previous treatment;

response to treatment;

time since treatment;

and recurrence risk.

Requirements vary substantially depending on the malignancy and transplant program.

Other serious medical conditions

Severe disease affecting other organs can influence transplant risk.

For example, a kidney transplant candidate may also have serious heart, lung, vascular or liver disease.

The transplant team must determine whether transplantation remains likely to provide an overall benefit.

Functional and nutritional status

Frailty, severe malnutrition or significant physical deconditioning can increase surgical and postoperative risk.

Some patients may be asked to improve nutrition, physical conditioning or another modifiable factor before transplantation is reconsidered.

This can sometimes be part of a pre-transplant optimization process.

Does age determine transplant eligibility?

Age can be relevant, but a date of birth alone does not usually provide the complete answer.

Transplant centers often consider physiological health and overall risk, not simply chronological age.

Two patients of the same age may have very different levels of frailty, cardiovascular health, independence and comorbidity.

Some transplant programs may nevertheless have organ-specific or program-specific age policies.

For international referrals, providing the patient's correct date of birth is therefore important from the beginning.

Does nationality or country of residence matter?

For international patients, yes—it can.

Nationality and country of residence may influence which transplant pathways are available because laws, organ-allocation systems and hospital policies differ between jurisdictions.

• For example, access to deceased-donor organs may be restricted or highly regulated for non-residents in some countries.
• Living-donor pathways may also have documentation requirements concerning:
• donor-recipient relationship
• residency
• nationality
• identity
• consent
• legal authorization.

This is why MedTransplant's international case intake should distinguish between a patient's nationality and country of residence.

They are not always the same.

What role does a living donor play in eligibility?

In certain transplant pathways—particularly kidney and liver transplantation—the availability of a potential living donor may influence which options can be evaluated.

However, the existence of a willing donor does not automatically make the recipient eligible.

Both individuals require separate assessment.

The recipient must be medically suitable for transplantation.

The donor must independently satisfy medical, psychosocial, ethical and legal requirements.

Does blood type determine transplant eligibility?

Blood group can be important, particularly when evaluating donor-recipient compatibility, but it is only one part of the assessment.

• Depending on the transplant type, the center may consider:
• ABO blood group
• HLA characteristics
• recipient antibodies
• crossmatch testing
• donor anatomy
• organ function
• other immunological factors.

Some specialized transplant centers may evaluate selected incompatible donor-recipient combinations through specific protocols.

Therefore, an apparent blood-group difference should not be interpreted without specialist evaluation.

Can obesity affect transplant eligibility?

Body weight and body mass index may be considered because obesity can increase surgical, cardiovascular, wound-healing and metabolic risks.

Some transplant programs have BMI thresholds or require weight reduction before proceeding.

However, eligibility policies vary.

Patients should avoid assuming that a particular BMI automatically means transplantation is impossible.

A transplant center should determine the significance of weight in the context of the patient's overall condition.

Can diabetes affect eligibility?

Diabetes itself does not necessarily prevent transplantation.

Many kidney transplant candidates have diabetes.

However, transplant teams may evaluate how well diabetes is controlled and whether complications such as cardiovascular disease, vascular disease or infection substantially increase risk.

In selected cases, transplant programs may consider combined or alternative transplant pathways depending on the patient's diagnosis and circumstances.

Does smoking affect transplant eligibility?

Active smoking may influence transplant candidacy because it can increase cardiovascular, pulmonary, cancer and wound-healing risks.

Some programs may require smoking cessation before listing or transplantation.

The specific requirements vary by transplant center and organ type.

Patients should provide accurate information about smoking and other substance use during evaluation.

What about alcohol or substance use?

Transplant centers may evaluate current and previous alcohol or substance use, depending on the organ involved and clinical context.

The purpose is not simply to label a patient.

Programs may need to understand:

• medical risk
• potential effects on the transplanted organ
• treatment adherence
• relapse risk
• the availability of appropriate support.

Requirements for abstinence, treatment or psychosocial evaluation vary considerably between programs.

Why does treatment adherence matter?

Transplantation requires long-term medical care.

After transplantation, patients may need lifelong immunosuppressive medications, frequent laboratory tests and ongoing specialist follow-up.

Missing medication doses can increase the risk of rejection or graft failure.

Transplant teams may therefore assess whether the patient understands the treatment plan and appears able to follow complex medical recommendations.

For international patients, this also raises an important question:

Will appropriate follow-up and medication access be available after the patient returns home?

What psychosocial factors may be evaluated?

Transplant evaluation is not purely surgical.

Depending on the program, teams may review:

• understanding of transplantation
• ability to provide informed consent
• social support
• mental-health concerns
• substance-use history
• medication adherence
• financial or logistical barriers to follow-up
• the patient's ability to manage long-term care.

These factors should be assessed in a medically appropriate and non-discriminatory way.

Can a patient initially be declined and later become eligible?

Examples might include:

• active infection
• uncontrolled cardiovascular disease
• incomplete cancer evaluation
• severe nutritional issues
• smoking
• inadequate medical documentation
• another treatable risk factor.

The patient may then be reassessed after the issue has been addressed.

In other circumstances, a transplant team may conclude that transplantation presents an unacceptably high risk or is unlikely to provide sufficient benefit.

Patients should ask whether a decision is:

temporary, potentially modifiable, or considered permanent under that program's criteria.

Can another transplant center give a different opinion?

Possibly.

Transplant programs do not always use identical eligibility criteria.

A complex patient may therefore seek another specialist opinion, particularly where there is genuine uncertainty or where another center has specific expertise.

However, a second opinion should not be used as a mechanism to bypass legitimate medical, ethical or legal requirements.

The goal should be to determine whether another appropriately qualified transplant program has a different evidence-based assessment.

What information should international patients prepare?

An initial international transplant enquiry may include:

• full name
• date of birth
• sex
• nationality
• country of residence
• diagnosis
• transplant type being considered
• current treatment
• relevant medical history
• current medications
• previous surgeries
• recent laboratory results
• imaging and reports
• specialist reports
• information about a potential living donor where applicable.
• A family member or trusted representative may sometimes submit the enquiry on the patient's behalf.
• The patient's information and the representative's contact information should remain clearly separated.

This helps the transplant program understand who the patient is and who is coordinating communication.

Should patients travel before knowing whether they may be evaluated?

An initial review may help determine:

• whether the center manages the relevant transplant type
• whether international patients are accepted
• whether important documentation is missing
• whether a potential donor pathway can be considered
• whether an in-person evaluation is appropriate.

Remote review cannot replace comprehensive evaluation, but it may prevent unnecessary international travel.

How MedTransplant supports international eligibility review

Patients searching for transplant options abroad often face an early practical problem:

They do not yet know which hospital is appropriate or whether their case is suitable for referral.

MedTransplant provides international transplant care navigation and patient referral support.

A patient—or family member or trusted representative—can submit available case information for an initial navigation review.

Depending on the case, MedTransplant may help:

• identify the relevant transplant pathway
• organize available medical information
• identify potentially appropriate transplant destinations and hospitals
• facilitate referral for independent hospital evaluation.

MedTransplant does not make the transplant eligibility decision.

It does not allocate organs, approve living donors, source human organs or guarantee transplantation.

The transplant center remains responsible for all clinical eligibility decisions.

Do you have a transplant case requiring international evaluation?

Submit the patient's available information and medical records to begin the referral process.

Continue exploring

Related MedTransplant guides

International transplant care

International Organ Transplantation: A Patient’s Guide to Safe and Ethical Care Abroad

Learn how international organ transplantation works, including eligibility, hospital evaluation, living donation, patient safety and ethical care abroad.

Read guide →

Hospital selection

How to Choose a Transplant Hospital Abroad: 10 Questions Patients Should Ask

Choosing a transplant hospital abroad requires more than comparing costs. Learn 10 questions about eligibility, donors, safety, ethics and follow-up before seeking international transplant care.

Read guide →

Kidney transplant

Kidney Transplant Abroad: Eligibility, Living Donors, Evaluation and Patient Safety

Considering a kidney transplant abroad? Learn about eligibility, living donor evaluation, hospital selection, safety, costs and international patient referral.

Read guide →